These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1156553)

  • 1. Serum anti-tumour antibodies and auto-antibodies in vitiligo.
    Woolfson H; Finn OA; Mackie RM; McQueen A; MacSween RN
    Br J Dermatol; 1975 Apr; 92(4):395-400. PubMed ID: 1156553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.
    Merimsky O; Shoenfeld Y; Yecheskel G; Chaitchik S; Azizi E; Fishman P
    Cancer Immunol Immunother; 1994 Jun; 38(6):411-6. PubMed ID: 8205563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. I. Circulating antibodies for cultured melanoma cells.
    Takei M; Mishima Y; Uda H
    J Cutan Pathol; 1984 Apr; 11(2):107-13. PubMed ID: 6376558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.
    Hann SK; Kim JB
    Yonsei Med J; 1995 Nov; 36(5):457-61. PubMed ID: 8546004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo.
    Galbraith GM; Miller D; Emerson DL
    Clin Immunol Immunopathol; 1988 Sep; 48(3):317-24. PubMed ID: 3042212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.
    Fishman P; Merimski O; Baharav E; Shoenfeld Y
    Cancer; 1997 Apr; 79(8):1461-4. PubMed ID: 9118024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo and malignant melanoma: a significant association?
    Gregor RT
    S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
    Seibert E; Sorg C; Happle R; Macher E
    Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.
    Naughton GK; Eisinger M; Bystryn JC
    J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal cytoplasmic antibodies. (Incidence and clinical significance).
    Betterle C; Peserico A; Bersani G; Rigon F; Del Prete G
    Ric Clin Lab; 1977; 7(3):242-51. PubMed ID: 343221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphocyte transformation by melanin antigens in vitiligo vulgaris and malignant melanoma (author's transl)].
    Yamada M; Fujimoto F; Higashi K; Yanase K; Oku T
    Nihon Hifuka Gakkai Zasshi; 1975 May; 85(6):351-8. PubMed ID: 1081153
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
    Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
    N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased incidence of antismooth muscle antibody in Korean vitiligo patients.
    Hann SK; Im S; Kim HI; Kim HS; Lee YJ; Park YK
    J Dermatol; 1993 Nov; 20(11):679-83. PubMed ID: 8300936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological associations of the halo naevus with cutaneous malignant melanoma.
    Copeman PW; Lewis MG; Phillips TM; Elliott PG
    Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
    Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
    Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to normal human melanocytes in vitiligo.
    Naughton GK; Eisinger M; Bystryn JC
    J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma-associated hypopigmentation: where are the antibodies?
    Merimsky O; Shoenfeld Y; Baharav E; Altomonte M; Chaitchik S; Maio M; Ferrone S; Fishman P
    Am J Clin Oncol; 1996 Dec; 19(6):613-8. PubMed ID: 8931683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in patients with vitiligo.
    Brostoff J
    Lancet; 1969 Jul; 2(7613):177-8. PubMed ID: 4183134
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
    Ackermann-Schopf CM
    Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.